# This mRNA vaccine could potentially prevent the deadliest form of skin cancer

https://mins.news/en/video/27394

- CBS News, 2026-08-20 14:15 UTC
- Health
- Original: https://www.youtube.com/watch?v=DBmws1H1irc

> Moderna and Merck say a personalized mRNA cancer vaccine used with Keytruda reduced the risk of melanoma returning and spreading in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert provide more information.

## Related coverage

- [Merck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue](https://mins.news/en/item/28563) — CNN, 2026-08-21
- [Moderna, Merck say mRNA treatment cuts melanoma recurrence, spread risk](https://mins.news/en/video/27354) — CNA, 2026-08-20
- [Why this mRNA cancer vaccine is raising new treatment hope](https://mins.news/en/video/26783) — Reuters, 2026-08-20
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19
- [Moderna-Merck combination succeeds in late-stage skin cancer trial](https://mins.news/en/item/26142) — CNN, 2026-08-19